The Efficacy and Safety of Panitumumab Administered Concomitantly With FOLFIRI or Irinotecan in Second-Line Therapy for Metastatic Colorectal Cancer: The Secondary Analysis From STEPP (Skin Toxicity Evaluation Protocol With Panitumumab) by KRAS Status-Reference-Cited by-同舟云学术

The Efficacy and Safety of Panitumumab Administered Concomitantly With FOLFIRI or Irinotecan in Second-Line Therapy for Metastatic Colorectal Cancer: The Secondary Analysis From STEPP (Skin Toxicity Evaluation Protocol With Panitumumab) by KRAS Status

Published:2011-12 Issue:4 Volume:10 Page:333-339
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Mitchell Edith P.,Piperdi Bilal,Lacouture Mario E.,Shearer Heather,Iannotti Nicholas,Pillai Madhavan V.,Xu Feng,Yassine Mohamed

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference16 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer;Cunningham;Lancet,1998

3. Phase III comparison of two irinotecan dosing regimens in second-line therapy of metastatic colorectal cancer;Fuchs;J Clin Oncol,2003

4. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer;Hurwitz;N Engl J Med,2004

5. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study;Tournigand;J Clin Oncol,2004

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2024-06

2. Panitumumab-Induced Periorbital Dermatitis: A Case Report;Clinical, Cosmetic and Investigational Dermatology;2024-04

3. Adjuvant Systemic Chemotherapy;Colorectal Liver Metastasis;2022

4. Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2021-03

The impact of panitumumab treatment on survival and quality of life in patients with RAS wild-type metastatic colorectal cancer

;Cancer Management and Research;2019-06